NASDAQ:IBBQ Invesco Nasdaq Biotechnology ETF (IBBQ) Price, Holdings, & News → The Military's $700M 'AI Software Bullet' (From Behind the Markets) (Ad) Free IBBQ Stock Alerts $22.39 -0.18 (-0.80%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$22.39▼$22.5350-Day Range$20.28▼$22.7952-Week Range$18.18▼$23.02Volume7,721 shsAverage Volume16,812 shsMarket Capitalization$32.91 millionAssets Under Management$33.20 millionDividend Yield0.80%Net Expense Ratio0.19% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Get Invesco Nasdaq Biotechnology ETF alerts: Email Address About Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.Read More IBBQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBBQ ETF News HeadlinesMay 13, 2024 | fool.comHow to Invest in Invesco QQQ TrustMay 13, 2024 | seekingalpha.comFor Biotech Stocks To Move Higher, This Must Move LowerMay 4, 2024 | finance.yahoo.comInvesco NASDAQ Biotech UCITS ETF (SBIO.SW)April 1, 2024 | msn.comQQQ ETF Update, 4/1/2024February 27, 2024 | markets.businessinsider.comVestmark In Partnership With Invesco On Portfolio SolutionsJanuary 10, 2024 | markets.businessinsider.comAnalyst Expectations For Invesco's FutureJanuary 9, 2024 | msn.comBiotech ETFs Stage Solid Comeback at the Start of 2024December 20, 2023 | msn.comInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.0526See More Headlines Receive IBBQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerInvesco Fund NameInvesco Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBBQ Inception Date6/11/2021 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Previous SymbolNASDAQ:IBBQ WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings220 Fund Statistics Assets Under Management$33.20 million Average Daily Volume$0.00 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerLatour Trading Miscellaneous Outstanding Shares1,470,000Beta0.61 Creation Unit10,000 Creation Fee$600.00 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Ad Weiss RatingsRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and radically change life in America as we know it today. And a Draconian set of technologies that could impose a new kind of financial surveillance in America. Click here to learn more. Invesco Nasdaq Biotechnology ETF ExpensesTypeIBBQHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.19%0.56%0.54%0.47%0.51%Other Expenses0.00%0.33%0.50%0.39%0.54%Total Expense0.19%0.70%0.70%0.60%0.71%Fee Waiver0.00%-0.45%-0.55%-0.32%-0.60%Net Expense0.19%0.61%0.60%0.54%0.58% Invesco Nasdaq Biotechnology ETF (IBBQ) Holdings & ExposureTop 10 IBBQ HoldingsVertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 9.23%Amgen(NASDAQ:AMGN)Holding Weight: 8.96%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 8.35%Gilead Sciences(NASDAQ:GILD)Holding Weight: 7.22%Moderna(NASDAQ:MRNA)Holding Weight: 5.92%AstraZeneca(NASDAQ:AZN)Holding Weight: 4.79%Biogen(NASDAQ:BIIB)Holding Weight: 3.36%Alnylam Pharmaceuticals(NASDAQ:ALNY)Holding Weight: 1.98%Illumina(NASDAQ:ILMN)Holding Weight: 1.86%BioMarin Pharmaceutical(NASDAQ:BMRN)Holding Weight: 1.57%IBBQ Sector ExposureIBBQ Industry ExposureFull Holdings Details Similar ETFsPrincipal Healthcare Innovators ETFNASDAQ:BTECFirst Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHHorizon Kinetics Medical ETFNASDAQ:MEDXJPMorgan Healthcare Leaders ETFNASDAQ:JDOCProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISInstitutional OwnershipLake Street Advisors Group LLCBought 12,917 shares on 5/14/2024Ownership: 0.879%Eudaimonia Advisors LLCBought 70,693 shares on 4/25/2024Ownership: 4.809%Eudaimonia Partners LLCBought 41,612 shares on 4/25/2024Ownership: 2.831%View All Institutional Transactions IBBQ ETF - Frequently Asked Questions How have IBBQ shares performed in 2024? Invesco Nasdaq Biotechnology ETF's stock was trading at $21.89 at the beginning of the year. Since then, IBBQ stock has increased by 2.3% and is now trading at $22.39. View the best growth stocks for 2024 here. Are investors shorting Invesco Nasdaq Biotechnology ETF? Invesco Nasdaq Biotechnology ETF saw a drop in short interest during the month of May. As of May 31st, there was short interest totaling 7,500 shares, a drop of 28.6% from the May 15th total of 10,500 shares. Based on an average trading volume of 13,100 shares, the days-to-cover ratio is currently 0.6 days. View Invesco Nasdaq Biotechnology ETF's Short Interest. How often does Invesco Nasdaq Biotechnology ETF pay dividends? What is the dividend yield for Invesco Nasdaq Biotechnology ETF? Invesco Nasdaq Biotechnology ETF announced a quarterly dividend on Friday, March 15th. Shareholders of record on Tuesday, March 19th will be paid a dividend of $0.0435 per share on Friday, March 22nd. This represents a $0.17 annualized dividend and a dividend yield of 0.78%. The ex-dividend date is Monday, March 18th. Read our dividend analysis for IBBQ. What does IBBQ invest in? Invesco Nasdaq Biotechnology ETF is a equity fund issued by Invesco. IBBQ focuses on health care investments and follows the Nasdaq Biotechnology Index. The fund's investments total to approximately $33.20 million assets under management. What stocks does Invesco Nasdaq Biotechnology ETF hold? IBBQ invests in 220 holdings. Some of the stocks in their portfolio include Vertex Pharmaceuticals (VRTX), Amgen (AMGN), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), Moderna (MRNA), AstraZeneca (AZN), Biogen (BIIB), Alnylam Pharmaceuticals (ALNY), Illumina (ILMN) and BioMarin Pharmaceutical (BMRN). What is the management fee for Invesco Nasdaq Biotechnology ETF? Invesco Nasdaq Biotechnology ETF's management fee is 0.19% and has no other recorded expenses or fee waivers. The net expense ratio for IBBQ is 0.19%. Who are Invesco Nasdaq Biotechnology ETF's major shareholders? Invesco Nasdaq Biotechnology ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Eudaimonia Advisors LLC (4.81%), Eudaimonia Partners LLC (2.83%) and Lake Street Advisors Group LLC (0.88%). How do I buy shares of Invesco Nasdaq Biotechnology ETF? Shares of IBBQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IBBQ) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.